We have shown previously that Vasoactive Intestinal Peptide (VIP) knockout mice develop spontaneous pulmonary hypertension and T lymphocytic infiltration of the airways and vasculature [18,19] and that administration of VIVIT peptide (an inhibitor of NFAT) reduces inflammation and pulmonary arterial remodeling in these mice. This evidence concerns the gene VIP and pulmonary hypertension.